HRMY:NASDAQ, Harmony Biosciences Holdings, Inc.

HRMY stock overview

Harmony Biosciences Holdings, Inc. (HRMY:NASDAQ) closed at $32.98 on November 19, 2026, down 0.39% on the day. The stock trades 24.2% below its 52-week high of $43.49 and 27.3% above its 52-week low of $25.90. Over the past year, it lost 1.2%. Harmony Biosciences Holdings, Inc. is part of the Health Care sector.

Key figures

Price
$32.98
Day change
-0.39%
Volume
804,704
Average volume
1,007,376
Market cap
1B+
52-week range
$25.90 – $43.49
50-day average
$38.11
200-day average
$34.51

Price action over the past year

In 252 trading sessions since November 19, 2025, HRMY closed higher on 129 days (51%). Its best day was July 21, 2026 (+9.97%) and its worst was February 20, 2026 (-15.21%). The stock moved 10% or more in a single session 1 time.

Recent signals

HRMY news

About Harmony Biosciences Holdings, Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing innovative therapies for patients living with rare neurological disorders who have unmet medical needs.

Similar stocks

Find more stocks like HRMY with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.